Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (151-160 of 412) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanomaSaadia A Aziz, Lucia B Jilaveanu, Christopher Zito, et al.
Cancer|February 24, 2012
Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancerMaria T Baquero, Jason A Hanna, Veronique Neumeister, et al.
Plos One|April 27, 2013
High SOX2 levels predict better outcome in non-small cell lung carcinomasVamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, et al.
Archives of Pathology & Laboratory Medicine|November 7, 2017
Worldwide Frequency of Commonly Detected EGFR MutationsRondell P Graham, Amanda L Treece, Neal I Lindeman, et al.
Cancer Research|January 26, 2002
Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray studyWen Xie, Joachim C Mertens, Daniel J Reiss, et al.
Molecular Cancer|June 17, 2010
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epitheliumJerzy Rokicki, Partha M Das, Jennifer M Giltnane, et al.
Breast Cancer Research and Treatment|July 18, 2025
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCISHaiying Zhan, Nay Nwe Nyein Chan, Revekka Khaimova, et al.
Cancers|November 13, 2021
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic CancerTyler MacNeil, Ioannis A Vathiotis, Saba Shafi, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Lin28 regulates HER2 and promotes malignancy through multiple mechanismsChen Feng, Veronique Neumeister, Wei Ma, et al.
BMC Cancer|June 3, 2014
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumabHuan Cheng, Yalai Bai, William Sikov, et al.
Pageof 42

Showing results (151-160 of 412) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanomaSaadia A Aziz, Lucia B Jilaveanu, Christopher Zito, et al.
Cancer|February 24, 2012
Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancerMaria T Baquero, Jason A Hanna, Veronique Neumeister, et al.
Plos One|April 27, 2013
High SOX2 levels predict better outcome in non-small cell lung carcinomasVamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, et al.
Archives of Pathology & Laboratory Medicine|November 7, 2017
Worldwide Frequency of Commonly Detected EGFR MutationsRondell P Graham, Amanda L Treece, Neal I Lindeman, et al.
Cancer Research|January 26, 2002
Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray studyWen Xie, Joachim C Mertens, Daniel J Reiss, et al.
Molecular Cancer|June 17, 2010
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epitheliumJerzy Rokicki, Partha M Das, Jennifer M Giltnane, et al.
Breast Cancer Research and Treatment|July 18, 2025
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCISHaiying Zhan, Nay Nwe Nyein Chan, Revekka Khaimova, et al.
Cancers|November 13, 2021
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic CancerTyler MacNeil, Ioannis A Vathiotis, Saba Shafi, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Lin28 regulates HER2 and promotes malignancy through multiple mechanismsChen Feng, Veronique Neumeister, Wei Ma, et al.
BMC Cancer|June 3, 2014
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumabHuan Cheng, Yalai Bai, William Sikov, et al.
Pageof 42